260 related articles for article (PubMed ID: 24275268)
1. Trichomoniasis: the "neglected" sexually transmitted disease.
Meites E
Infect Dis Clin North Am; 2013 Dec; 27(4):755-64. PubMed ID: 24275268
[TBL] [Abstract][Full Text] [Related]
2. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
4. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
[TBL] [Abstract][Full Text] [Related]
5. Trichomoniasis.
Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
[TBL] [Abstract][Full Text] [Related]
6. Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection.
Getaneh FW; Oliveira CR; Pathy S; Sheth SS
Am J Obstet Gynecol; 2023 Sep; 229(3):284.e1-284.e10. PubMed ID: 37393012
[TBL] [Abstract][Full Text] [Related]
7. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic options for the treatment of human trichomoniasis.
Küng E; Fürnkranz U; Walochnik J
Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
[TBL] [Abstract][Full Text] [Related]
9. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
10. Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community.
Munson E; Napierala M; Schell RF
Expert Rev Anti Infect Ther; 2013 Aug; 11(8):845-63. PubMed ID: 23944153
[TBL] [Abstract][Full Text] [Related]
11. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.
Sherrard J; Ison C; Moody J; Wainwright E; Wilson J; Sullivan A
Int J STD AIDS; 2014 Jul; 25(8):541-9. PubMed ID: 24616117
[TBL] [Abstract][Full Text] [Related]
12. Trichomoniasis in teens: an update.
Huppert JS
Curr Opin Obstet Gynecol; 2009 Oct; 21(5):371-8. PubMed ID: 19491679
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-Resistant Trichomoniasis: Successful Treatment With 3 Months of Twice-Daily Intravaginal Boric Acid.
Seyedroudbari S; McCloskey K; Muzny CA; Graziani A; Momplaisir F
Sex Transm Dis; 2023 Jul; 50(7):452-454. PubMed ID: 36940199
[TBL] [Abstract][Full Text] [Related]
14. [Trichomoniasis].
Yasuda J
Nihon Rinsho; 2009 Jan; 67(1):162-6. PubMed ID: 19177767
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
16. Infectious disease: New Trichs: screening and therapy.
Killock D
Nat Rev Urol; 2014 Aug; 11(8):427. PubMed ID: 24980196
[No Abstract] [Full Text] [Related]
17. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
Van der Pol B
Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
[No Abstract] [Full Text] [Related]
18. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine.
Cudmore SL; Garber GE
J Infect Public Health; 2010; 3(2):47-53. PubMed ID: 20701891
[TBL] [Abstract][Full Text] [Related]
19. British Association for Sexual Health and HIV (BASHH) United Kingdom national guideline on the management of
Sherrard J; Pitt R; Hobbs KR; Maynard M; Cochrane E; Wilson J; Tipple C
Int J STD AIDS; 2022 Jul; 33(8):740-750. PubMed ID: 35701863
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea.
Kim SR; Kim JH; Gu NY; Kim YS; Hong YC; Ryu JS
Korean J Parasitol; 2016 Apr; 54(2):187-90. PubMed ID: 27180577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
